Ingrezza is used to treat a disorder known as tardive dyskinesia (TD). It is a neurological condition marked by uncontrollable and repetitive movements of the tongue, face, and other body parts.

As previously indicated, it is primarily used to treat tardive dyskinesia (TD). Let’s examine its applications and advantages in more detail:

Tardive dyskinesia: Uncontrollable and repetitive movements of the face, tongue, and other body parts are the hallmarks of this condition.

Dopamine control: A vesicular monoamine transporter inhibitor, the active component, updates certain neurotransmitters, including dopamine, into nerve cells.

Symptom Management of TD: While it doesn’t treat the underlying cause, it is essential in treating the symptom. Reducing uncontrollable movements can enhance a patient’s motor function, general functioning, and quality of life.

Common adverse effects include:

• Sleepiness or fatigue
• Balance problems
• Changes in heart rhythm
• Parkinsonism
• Restlessness or Akathisia
• Nausea
• Dry mouth
• Abnormal liver function

• Medical history
• Current medicines
• Allergies
• Both breastfeeding and pregnancy
• Driving as well as operating equipment
• Alcohol and sedatives
• QT prolongation
• Liver function